Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

MLN4924, an NAE inhibitor, suppresses AKT and mTOR signaling via upregulation of REDD1 in human myeloma cells

Yanyan Gu, Jonathan L. Kaufman, Leon Bernal, Claire Torre, Shannon M. Matulis, R. Donald Harvey, Jing Chen, Shi-Yong Sun, Lawrence H. Boise, Sagar Lonial

Blood (2014) 123 (21): 3269–3276.

https://doi.org/10.1182/blood-2013-08-521914

Published: 2014

Includes: Supplemental data

Journal Articles

Combined Carfilzomib and Selective PI3Kδ Inhibition (TGR1202) Results In Enhanced Myeloma Cell Apoptosis

Claire Torre, Yanyan Gu, MD, PhD, Lawrence H. Boise, PhD, Sagar Lonial, M.D.

Blood (2013) 122 (21): 3224.

https://doi.org/10.1182/blood.V122.21.3224.3224

Published: 2013

Journal Articles

Tipifarnib sensitizes cells to proteasome inhibition by blocking degradation of bortezomib-induced aggresomes

Ebenezer David, Jonathan L. Kaufman, Christopher R. Flowers, Katherine Schafer-Hales, Claire Torre, Jing Chen, Adam I. Marcus, Shi-Yong Sun, Lawrence H. Boise, Sagar Lonial

Blood (2010) 116 (24): 5285–5288.

https://doi.org/10.1182/blood-2010-03-272393

Published: 2010

Includes: Supplemental data

Journal Articles

A Randomized Phase I Trial of Melphalan + Bortezomib as Conditioning for Autologous Transplant for Myeloma: The Effect of Sequence of Administration.

Sagar Lonial, MD, Jonathan Kaufman, MD, Claire Torre, Amelia Langston, Mary J. Lechowicz, Christopher Flowers, Stephanie McMillan, Heather Renfroe, Leonard T Heffner, Edmund K Waller

Blood (2008) 112 (11): 3332.

https://doi.org/10.1182/blood.V112.11.3332.3332

Published: 2008

Journal Articles

A Novel Pan-PI3K/Akt Inhibitor, SF1126, Inhibits In Vitro Growth of Multiple Myeloma Cells.

Jeannine Silberman, MD, Kimberly Dalbey, BS, Claire Torre, Ebenezer David, PhD, Leif Bergsagel, MD, Donald Durden, MD, PhD, Joseph Garlich, PhD, Ulrich Schwertschlag, MD, PhD, Sagar Lonial, MD

Blood (2007) 110 (11): 4806.

https://doi.org/10.1182/blood.V110.11.4806.4806

Published: 2007

Journal Articles

A Randomized Phase I Trial of Melphalan + Bortezomib as Conditioning for Autologous Transplant for Myeloma: The Effect of Sequence of Administration.

Sagar Lonial, MD, Jonathan Kaufman, MD, Amelia A. Langston, MD, Leonard T. Heffner, MD, Claire Torre, Mary J. Lechowicz, MD, Christopher Flowers, MD, Stephanie McMillan, RN, Michael Arnold, Ned K. Waller, MD, PhD

Blood (2007) 110 (11): 949.

https://doi.org/10.1182/blood.V110.11.949.949

Published: 2007

Journal Articles

A Randomized Trial To Evaluate the Impact of Cytokines (G-CSF or GM + G-CSF) on Dendritic Cell and T-Cell Content and Function When Mobilizing Normal Donors for Allogeneic Progenitor Cell Transplant.

Sagar Lonial, MD, Stephanie McMillan, Claire Torre, Amelia A. Langston, MD, Ellie Hamilton, Amanda Cook, Christopher Flowers, MD, Jonathan L. Kaufman, MD, Mary Jo Lechowicz, MD, Ned Waller, MD

Blood (2006) 108 (11): 3377.

https://doi.org/10.1182/blood.V108.11.3377.3377

Published: 2006

Journal Articles

Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myeloma

Blood (2005) 106 (12): 3777–3784.

https://doi.org/10.1182/blood-2005-03-1173

Published: 2005

Journal Articles

A Randomized Trial To Evaluate the Impact of Cytokines (G-CSF or GM + G-CSF) on Dendritic Cell and T-Cell Content and Function When Mobilizing Normal Donors for Allogeneic Progenitor Cell Transplant.

Sagar Lonial, MD, Claire Torre, Amelia A. Langston, MD, Stephanie McMillan, Ellie Hamilton, Christopher Flowers, MD, Mary J. Lechowicz, MD, Edmund K. Waller, MD, PhD

Blood (2005) 106 (11): 1960.

https://doi.org/10.1182/blood.V106.11.1960.1960

Published: 2005

Journal Articles

Combination of Akt/PKB Inhibition (Perifosine) and Farnesyl Transferase Inhibition (Tipifarnib) Results in Increased Cell Death in Myeloma Cells Lines.

Rajni Sinha, MD, Ebenezer David, PhD, Emily Zeilter, Claire Torre, Jonathan L. Kaufman, MD, Sagar Lonial, MD

Blood (2005) 106 (11): 1568.

https://doi.org/10.1182/blood.V106.11.1568.1568

Published: 2005

Journal Articles

Combination of Farnesyl Transferase Inhibitor (Tipifarnib) with Perifosine Induces Apoptosis through phos-PDK1 in Human Lymphoma and Leukemia Cell Lines.

Ebenezer David, PhD, Rajni Sinha, MD, Claire Torre, Jonathan L. Kaufman, MD, Sagar Lonial, MD

Blood (2005) 106 (11): 1488.

https://doi.org/10.1182/blood.V106.11.1488.1488

Published: 2005

Journal Articles

A Randomized Trial to Evaluate the Impact of Cytokines on Dendritic Cell, T-Cell and T-Cell Function When Mobilizing Normal Donors for Allogeneic Progenitor Cell Transplant: An Interim Analysis.

Sagar Lonial, MD, Claire Torre, Michelle Hicks, Stephanie Mcmillan, Amelia A. Langston, MD, Christopher R. Flowers, MD, Mary J. Lechowicz, MD, Edmund K. Waller, MD, PhD

Blood (2004) 104 (11): 2854.

https://doi.org/10.1182/blood.V104.11.2854.2854

Published: 2004

NARROW

MLN4924, an NAE inhibitor, suppresses AKT and mTOR signaling via upregulation of REDD1 in human myeloma cells

Combined Carfilzomib and Selective PI3Kδ Inhibition (TGR1202) Results In Enhanced Myeloma Cell Apoptosis

Tipifarnib sensitizes cells to proteasome inhibition by blocking degradation of bortezomib-induced aggresomes

A Randomized Phase I Trial of Melphalan + Bortezomib as Conditioning for Autologous Transplant for Myeloma: The Effect of Sequence of Administration.

A Novel Pan-PI3K/Akt Inhibitor, SF1126, Inhibits In Vitro Growth of Multiple Myeloma Cells.

A Randomized Phase I Trial of Melphalan + Bortezomib as Conditioning for Autologous Transplant for Myeloma: The Effect of Sequence of Administration.

A Randomized Trial To Evaluate the Impact of Cytokines (G-CSF or GM + G-CSF) on Dendritic Cell and T-Cell Content and Function When Mobilizing Normal Donors for Allogeneic Progenitor Cell Transplant.

Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myeloma

A Randomized Trial To Evaluate the Impact of Cytokines (G-CSF or GM + G-CSF) on Dendritic Cell and T-Cell Content and Function When Mobilizing Normal Donors for Allogeneic Progenitor Cell Transplant.

Combination of Akt/PKB Inhibition (Perifosine) and Farnesyl Transferase Inhibition (Tipifarnib) Results in Increased Cell Death in Myeloma Cells Lines.

Combination of Farnesyl Transferase Inhibitor (Tipifarnib) with Perifosine Induces Apoptosis through phos-PDK1 in Human Lymphoma and Leukemia Cell Lines.

A Randomized Trial to Evaluate the Impact of Cytokines on Dendritic Cell, T-Cell and T-Cell Function When Mobilizing Normal Donors for Allogeneic Progenitor Cell Transplant: An Interim Analysis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only